Leerink Partners analyst Jonathan Chang has maintained their bullish stance on IMTX stock, giving a Buy rating on November 6. Jonathan ...

Immatics (IMTX) has released an update. Immatics is showcasing promising advancements in its TCR-T therapy candidates targeting PRAME, with ...

Avidity Biosciences, Inc. (RNA) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2024. This widely-known consensus ...

Immatics (IMTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

A council plans on battling “the plague” of shopping trolleys dumped in its rivers and streets by hitting supermarkets harder in the pocket. A wildlife reserve visitor centre has been damaged ...

Ownership research along with analyst forecasts data help provide a good understanding of opportunities in a stock To get a sense of who is truly in control of Immatics N.V. (NASDAQ:IMTX), it is ...

Ownership research along with analyst forecasts data help provide a good understanding of opportunities in a stock To get a sense of who is truly in control of Immatics N.V. (NASDAQ:IMTX), it is ...

Immatics (NASDAQ:IMTX – Get Free Report) was the recipient of a significant drop in short interest during the month of September.As of September 30th, there was short interest totalling ...